Depomed Announces First Quarter 2017 Financial Results and Strategic Initiatives Aimed at Driving Sustainable Long-Term Growth and Shareholder Value

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Depomed Announces First Quarter 2017 Financial Results and Strategic Initiatives Aimed at Driving Sustainable Long-Term Growth and Shareholder Value

DepoMed Inc (DEPO) PT Lowered to $13 at RBC Capital; Magnitude of Reset was a Suprise

May 10, 2017 6:24 AM EDT

RBC Capital lowered its price target on DepoMed Inc (NASDAQ: DEPO) to $13.00 (from $19.00) while maintaining a Sector Perform rating following a sizable reset on outlook.

Analyst Randall Stanicky said the reset is not a surprise given new CEO but magnitude... More

Depomed (DEPO) Misses Q1 EPS by 7c; Guides Below

May 9, 2017 4:08 PM EDT

Depomed (NASDAQ: DEPO) reported Q1 EPS of $0.07, $0.07 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $95 million versus the consensus estimate of $103.06 million.

GUIDANCE:

Depomed sees FY2017 revenue of $410-430 million, versus the consensus of $473 million.

I am excited to have... More